Aerosol-generating Procedures amid Coronavirus Outbreak Compel Interventional Pulmonologists to Adopt New Practices

The coronavirus disease has increased the risk of human-to-human transmission of respiratory droplets coupled with a high level of population mobility, and has resulted in a rapid dissemination worldwide. This has increased the role of healthcare facilities and stakeholders in the global interventional pulmonology market. With a high number of active COVID-19 cases in Singapore, India, Canada, and Pakistan, interventional pulmonologists (IP) are also being exposed to the risk of infection. Hence, companies in the interventional pulmonology market are maintaining robust supply chains of devices, medications, catheters, and stents, among others, to reduce the vulnerability of healthcare systems.

Similar to other open airway procedures or aerosol-generating procedures, bronchoscopy poses a significant risk of spreading contaminated droplets. Interventional pulmonologists are adapting to such high-risk procedures in order to ensure the safety of patients and other medical workers. Since there is a high risk of contracting the novel infection even after two doses of vaccination, interventional pulmonologists and related stakeholders in the value chain are maintaining optimum medical services to improve clinical outcomes.

interventional pulmonology market infographic

Request a sample to get extensive insights into the Interventional Pulmonology Market

Targeted Therapies, Collaboration among IP Workforce Help Improve Medical Outcomes

The interventional pulmonology market is projected to surpass US$ 8 Bn by 2031. Lung cancer diagnosis, staging, and management of the pulmonary nodule contribute to a significant portion of an IP’s work. Since lung cancer screening programs are surging in many parts of the world, it is highly possible that the workload of IPs will increase in the future. However, targeting the peripheral pulmonary nodule as well as accurate mediastinal staging is a daily challenge for the IP workforce. In order to tide over these challenges, stakeholders are mainly focusing on personalized medicine, targeted therapies, and collaboration among IP, medical oncology, and pathology to ensure patient quality of life (QOL).

To understand how our report can bring difference to your business strategy, Ask for a brochure

Robotic Bronchoscopy Platforms Show Potential in Accurate Diagnosis of Lung Cancer

Robotic bronchoscopy is emerging as a game changer in the interventional pulmonology market. This explains why the market is estimated to register a striking CAGR of 8.7% during the forecast period. Companies are expected to collaborate with researchers to innovate in novel robotic bronchoscopy platforms that allow pulmonologists to clearly see and reach lung nodules without invasive surgery.

Rapid and accurate diagnosis of lung cancer have become the need of the hour in the interventional pulmonology market. This has triggered developments in robotic bronchoscopy platforms, which consist of a hand-held controller used to direct a small, flexible endoscope into the lung using a computer-assisted navigation. In this platform, the camera allows the physician to view a magnified image of the lung, which helps to deliver rapid and accurate diagnosis of lung cancer.

Strategic Acquisitions Help Expand Respiratory Portfolio, Accelerate Medical Processes

Inorganic business strategies such as mergers & acquisitions are growing prominent in the interventional pulmonology market. Olympus Corporation - a Japan-based manufacturer of optics and reprography products has announced the acquisition of Veran Medical Technologies, Inc. - a medical equipment manufacturer in Overland, Missouri, in order to expand its respiratory portfolio. Competitor companies in the interventional pulmonology market are determined to focus and scale their therapeutic solutions division to gain an edge over other market players. North America holds lucrative opportunities to accelerate processes and provide agility in the pulmonology therapeutics division.

interventional pulmonology market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Interventional Pulmonology Market

Analysts’ Viewpoint

IPs are adapting to new processes amid the ongoing coronavirus outbreak by adhering to a set of recommendations on how to perform bronchoscopy or pleural procedures safely to avoid contracting the infection. Navigational platforms and proprietary devices by companies are accelerating care in the lung cancer therapeutics division. However, in many cases, cancerous nodules in the lungs can be small and found in hard-to-reach areas, thus making biopsies difficult. Hence, companies in the interventional pulmonology market should increase their R&D activities in robotic pulmonary platforms to help IPs attain a magnified view of the lungs during the procedures.

Interventional Pulmonology Market: Overview

  • This report analyzes the current scenario and future prospects of the global interventional pulmonology market. Interventional pulmonology uses endoscopy and other devices to diagnose and treat conditions in the lungs and chest by using minimally invasive techniques. Significant applications of interventional pulmonology devices are projected to boost the growth of the global interventional pulmonology market from 2021 to 2031.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global interventional pulmonology market. It also provides information and data analysis of the global interventional pulmonology market with regards to segments based on product type, indication, end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that impact the global interventional pulmonology market
  • The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global interventional pulmonology market
  • The report on the global interventional pulmonology market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global interventional pulmonology market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global interventional pulmonology market.

Interventional Pulmonology Market: Key Segments

  • In terms of product type, the global interventional pulmonology market has been classified into bronchoscopes, electromagnetic navigation bronchoscopy systems, pleuroscopes, respiratory endotherapy devices, airway stents, pleural catheters, endobronchial valves, and bronchial thermoplasty systems
  • Based on indication, the global interventional pulmonology market has been categorized into asthma, COPD, lung cancer, tracheal & bronchial stenosis, and others
  • In terms of end user, the global interventional pulmonology market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, specialty clinics, and others
  • Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided from 2021 to 2031, considering 2020 as the base year.

Interventional Pulmonology Market: Regional Outlook

  • In terms of region, the global interventional pulmonology market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The global interventional pulmonology market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The interventional pulmonology market study also covers the competitive scenario in these regions.

Companies Covered in Interventional Pulmonology Market Report

  • Key players in the global interventional pulmonology market have been profiled based on attributes such as company overview, product portfolio, financial overview, strategic overview, recent developments, and competitive business strategies
  • Major companies profiled in the global interventional pulmonology market report are
    • Argon Medical
    • Body Vision Medical Ltd.
    • Boston Scientific Corporation
    • C. R. Bard, Inc. (Becton, Dickinson and Company)
    • CONMED Corporation
    • Cook
    • ENDO-FLEX GmbH
    • Fujifilm Corporation
    • KARL STORZ SE & Co. KG
    • Medtronic
    • Olympus Corporation
    • Pennine Healthcare
    • PENTAX Medical
    • Pulmonx Corporation
    • Richard Wolf GmbH
    • Rocket Medical plc.
    • TAEWOONG
    • Vygon
    • among others

Interventional Pulmonology Market – Segmentation

Product Type
  • Bronchoscopes
    • Flexible Bronchoscopes
    • Endobronchial Ultrasound Bronchoscopes (EBUS)
  • Electromagnetic Navigation Bronchoscopy Systems
  • Pleuroscopes
  • Respiratory Endotherapy Devices
    • Aspiration Needles
    • Biopsy Forceps
    • Biopsy Brush
    • Biopsy Needles
    • Catheter
    • Pulmonary Catheter
    • Balloon Dilatation Catheter
    • Others
  • Airway Stents
  • Pleural Catheters
  • Endobronchial Valves
  • Bronchial Thermoplasty Systems
Indication
  • COPD
  • Asthma
  • Lung Cancer
  • Tracheal & Bronchial Stenosis
  • Others
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Specialty Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Interventional pulmonology market is projected to surpass US$ 8 Bn by 2031

Interventional pulmonology market is projected to expand at a CAGR of ~9% from 2021 to 2031

Interventional pulmonology market is driven by rise in prevalence of respiratory disorders, increase in geriatric population, and surge in incidence of diseases that require endoscopic ultrasound procedures

North America is anticipated to account for a leading share of the global interventional pulmonology market during the forecast period

Key players operating in the global interventional pulmonology market are Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Interventional Pulmonology Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Interventional Pulmonology Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections 

5. Key Insights

    5.1. Regulatory Scenario by Region/globally

    5.2. Key Industry Events

    5.3. Disease Prevalence & Incidence Rate globally with key countries

    5.4. COVID-19 Impact Analysis

    5.5. Volume (No. of Procedures)

6. Global Interventional Pulmonology Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Product Type, 2017–2031

        6.3.1. Bronchoscopes

            6.3.1.1. Flexible Bronchoscopes

            6.3.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)

        6.3.2. Electromagnetic Navigation Bronchoscopy Systems

        6.3.3. Pleuroscopes

        6.3.4. Respiratory Endotherapy Devices

            6.3.4.1. Aspiration Needles

            6.3.4.2. Biopsy Forceps

            6.3.4.3. Biopsy Brush

            6.3.4.4. Biopsy Needles

            6.3.4.5. Drainage Catheter

            6.3.4.6. Pulmonary Catheter

            6.3.4.7. Balloon Dilatation Catheter

            6.3.4.8. Others (airway retrieval basket, airway suction catheter)

        6.3.5. Airway Stents

        6.3.6. Pleural Catheters

        6.3.7. Endobronchial Valves

        6.3.8. Bronchial Thermoplasty Systems

    6.4. Market Attractiveness Analysis, by Product Type 

7. Global Interventional Pulmonology Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. Asthma

        7.3.2. COPD

        7.3.3. Lung Cancer

        7.3.4. Tracheal & Bronchial Stenosis

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Indication 

8. Global Interventional Pulmonology Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Diagnostic Centers

        8.3.4. Specialty Clinics

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by End-user 

9. Global Interventional Pulmonology Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value & Volume Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Interventional Pulmonology Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        10.2.1. Bronchoscopes

            10.2.1.1. Flexible Bronchoscopes

            10.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)

        10.2.2. Electromagnetic Navigation Bronchoscopy Systems

        10.2.3. Pleuroscopes

        10.2.4. Respiratory Endotherapy Devices

            10.2.4.1. Aspiration Needles

            10.2.4.2. Biopsy Forceps

            10.2.4.3. Biopsy Brush

            10.2.4.4. Biopsy Needles

            10.2.4.5. Drainage Catheter

            10.2.4.6. Pulmonary Catheter

            10.2.4.7. Balloon Dilatation Catheter

            10.2.4.8. Others (airway retrieval basket, airway suction catheter)

        10.2.5. Airway Stents

        10.2.6. Pleural Catheters

        10.2.7. Endobronchial Valves

        10.2.8. Bronchial Thermoplasty Systems

    10.3. Market Value Forecast, by Indication, 2017–2031

        10.3.1. Asthma

        10.3.2. COPD

        10.3.3. Lung Cancer

        10.3.4. Tracheal & Bronchial Stenosis

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Diagnostic Centers

        10.4.4. Specialty Clinics

        10.4.5. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Product Type 

        10.6.2. By Indication 

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Interventional Pulmonology Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        11.2.1. Bronchoscopes

            11.2.1.1. Flexible Bronchoscopes

            11.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)

        11.2.2. Electromagnetic Navigation Bronchoscopy Systems

        11.2.3. Pleuroscopes

        11.2.4. Respiratory Endotherapy Devices

            11.2.4.1. Aspiration Needles

            11.2.4.2. Biopsy Forceps

            11.2.4.3. Biopsy Brush

            11.2.4.4. Biopsy Needles

            11.2.4.5. Drainage Catheter

            11.2.4.6. Pulmonary Catheter

            11.2.4.7. Balloon Dilatation Catheter

            11.2.4.8. Others (airway retrieval basket, airway suction catheter)

        11.2.5. Airway Stents

        11.2.6. Pleural Catheters

        11.2.7. Endobronchial Valves

        11.2.8. Bronchial Thermoplasty Systems

    11.3. Market Value Forecast, by Indication, 2017–2031

        11.3.1. Asthma

        11.3.2. COPD

        11.3.3. Lung Cancer

        11.3.4. Tracheal & Bronchial Stenosis

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Diagnostic Centers

        11.4.4. Specialty Clinics

        11.4.5. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Product Type 

        11.6.2. By Indication 

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Interventional Pulmonology Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        12.2.1. Bronchoscopes

            12.2.1.1. Flexible Bronchoscopes

            12.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)

        12.2.2. Electromagnetic Navigation Bronchoscopy Systems

        12.2.3. Pleuroscopes

        12.2.4. Respiratory Endotherapy Devices

            12.2.4.1. Aspiration Needles

            12.2.4.2. Biopsy Forceps

            12.2.4.3. Biopsy Brush

            12.2.4.4. Biopsy Needles

            12.2.4.5. Drainage Catheter

            12.2.4.6. Pulmonary Catheter

            12.2.4.7. Balloon Dilatation Catheter

            12.2.4.8. Others (airway retrieval basket, airway suction catheter)

        12.2.5. Airway Stents

        12.2.6. Pleural Catheters

        12.2.7. Endobronchial Valves

        12.2.8. Bronchial Thermoplasty Systems

    12.3. Market Value Forecast, by Indication, 2017–2031

        12.3.1. Asthma

        12.3.2. COPD

        12.3.3. Lung Cancer

        12.3.4. Tracheal & Bronchial Stenosis

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Diagnostic Centers

        12.4.4. Specialty Clinics

        12.4.5. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. Japan

        12.5.2. China

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Product Type 

        12.6.2. By Indication 

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Interventional Pulmonology Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        13.2.1. Bronchoscopes

            13.2.1.1. Flexible Bronchoscopes

            13.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)

        13.2.2. Electromagnetic Navigation Bronchoscopy Systems

        13.2.3. Pleuroscopes

        13.2.4. Respiratory Endotherapy Devices

            13.2.4.1. Aspiration Needles

            13.2.4.2. Biopsy Forceps

            13.2.4.3. Biopsy Brush

            13.2.4.4. Biopsy Needles

            13.2.4.5. Drainage Catheter

            13.2.4.6. Pulmonary Catheter

            13.2.4.7. Balloon Dilatation Catheter

            13.2.4.8. Others (airway retrieval basket, airway suction catheter)

        13.2.5. Airway Stents

        13.2.6. Pleural Catheters

        13.2.7. Endobronchial Valves

        13.2.8. Bronchial Thermoplasty Systems

    13.3. Market Value Forecast, by Indication, 2017–2031

        13.3.1. Asthma

        13.3.2. COPD

        13.3.3. Lung Cancer

        13.3.4. Tracheal & Bronchial Stenosis

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Diagnostic Centers

        13.4.4. Specialty Clinics

        13.4.5. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Product Type 

        13.6.2. By Indication 

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Interventional Pulmonology Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value & Volume Forecast, by Product Type, 2017–2031

        14.2.1. Bronchoscopes

            14.2.1.1. Flexible Bronchoscopes

            14.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)

        14.2.2. Electromagnetic Navigation Bronchoscopy Systems

        14.2.3. Pleuroscopes

        14.2.4. Respiratory Endotherapy Devices

            14.2.4.1. Aspiration Needles

            14.2.4.2. Biopsy Forceps

            14.2.4.3. Biopsy Brush

            14.2.4.4. Biopsy Needles

            14.2.4.5. Drainage Catheter

            14.2.4.6. Pulmonary Catheter

            14.2.4.7. Balloon Dilatation Catheter

            14.2.4.8. Others (airway retrieval basket, airway suction catheter)

        14.2.5. Airway Stents

        14.2.6. Pleural Catheters

        14.2.7. Endobronchial Valves

        14.2.8. Bronchial Thermoplasty Systems

    14.3. Market Value Forecast, by Indication, 2017–2031

        14.3.1. Asthma

        14.3.2. COPD

        14.3.3. Lung Cancer

        14.3.4. Tracheal & Bronchial Stenosis

        14.3.5. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Diagnostic Centers

        14.4.4. Specialty Clinics

        14.4.5. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East

    14.6. Market Attractiveness Analysis 

        14.6.1. By Product Type 

        14.6.2. By Indication 

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Company Profiles

        15.2.1. Argon Medical

            15.2.1.1. Company Description

            15.2.1.2. Business Overview

            15.2.1.3. Strategic Overview

            15.2.1.4. SWOT Analysis

        15.2.2. Body Vision Medical Ltd.

            15.2.2.1. Company Description

            15.2.2.2. Business Overview

            15.2.2.3. Strategic Overview

            15.2.2.4. SWOT Analysis

        15.2.3. Boston Scientific Corporation

            15.2.3.1. Company Description

            15.2.3.2. Business Overview

            15.2.3.3. Financial Overview

            15.2.3.4. Strategic Overview

            15.2.3.5. SWOT Analysis

        15.2.4. C. R. Bard, Inc. (Becton, Dickinson and Company)

            15.2.4.1. Company Description

            15.2.4.2. Business Overview

            15.2.4.3. Financial Overview

            15.2.4.4. Strategic Overview

            15.2.4.5. SWOT Analysis

        15.2.5. CONMED Corporation

            15.2.5.1. Company Description

            15.2.5.2. Business Overview

            15.2.5.3. Financial Overview

            15.2.5.4. Strategic Overview

            15.2.5.5. SWOT Analysis

        15.2.6. Cook Medical

            15.2.6.1. Company Description

            15.2.6.2. Business Overview

            15.2.6.3. Strategic Overview

            15.2.6.4. SWOT Analysis

        15.2.7. ENDO-FLEX GmbH

            15.2.7.1. Company Description

            15.2.7.2. Business Overview

            15.2.7.3. SWOT Analysis

        15.2.8. Fujifilm Holding Corporation

            15.2.8.1. Company Description

            15.2.8.2. Business Overview

            15.2.8.3. Financial Overview

            15.2.8.4. Strategic Overview

            15.2.8.5. SWOT Analysis

        15.2.9. KARL STORZ

            15.2.9.1. Company Description

            15.2.9.2. Business Overview

            15.2.9.3. Strategic Overview

            15.2.9.4. SWOT Analysis

        15.2.10. Medtronic plc

            15.2.10.1. Company Description

            15.2.10.2. Business Overview

            15.2.10.3. Financial Overview

            15.2.10.4. Strategic Overview

            15.2.10.5. SWOT Analysis

        15.2.11. Olympus Corporation

            15.2.11.1. Company Description

            15.2.11.2. Business Overview

            15.2.11.3. Financial Overview

            15.2.11.4. Strategic Overview

            15.2.11.5. SWOT Analysis

        15.2.12. Pennine Healthcare

            15.2.12.1. Company Description

            15.2.12.2. Business Overview

            15.2.12.3. SWOT Analysis

        15.2.13. PENTAX Medical (HOYA)

            15.2.13.1. Company Description

            15.2.13.2. Business Overview

            15.2.13.3. Financial Overview

            15.2.13.4. Strategic Overview

            15.2.13.5. SWOT Analysis

        15.2.14. Pulmonx Corporation

            15.2.14.1. Company Description

            15.2.14.2. Business Overview

            15.2.14.3. Financial Overview

            15.2.14.4. Strategic Overview

            15.2.14.5. SWOT Analysis

        15.2.15. Richard Wolf GmbH

            15.2.15.1. Company Description

            15.2.15.2. Business Overview

            15.2.15.3. Strategic Overview

            15.2.15.4. SWOT Analysis

        15.2.16. Rocket Medical plc

            15.2.16.1. Company Description

            15.2.16.2. Business Overview

            15.2.16.3. Strategic Overview

            15.2.16.4. SWOT Analysis

        15.2.17. TAEWOONG

            15.2.17.1. Company Description

            15.2.17.2. Business Overview

            15.2.17.3. SWOT Analysis

        15.2.18. Vygon S.A.

            15.2.18.1. Company Description

            15.2.18.2. Business Overview

            15.2.18.3. Strategic Overview

            15.2.18.4. SWOT Analysis

List of Tables

Table 01: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031

Table 03: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 04: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 05: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 06: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Region, 2017–2031

Table 09: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: North America Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031

Table 12: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 13: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 14: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 15: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Europe Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031

Table 19: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 20: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 21: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 22: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 23: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 25: Asia Pacific Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031

Table 26: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 28: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 29: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 30: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 31: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 32: Latin America Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031

Table 33: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 34: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 35: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 36: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 37: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 38: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 39: Middle East & Africa Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031

Table 40: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 41: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 42: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 43: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Interventional Pulmonology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 02: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, 2017–2031

Figure 03: Global Interventional Pulmonology Market Value Share, by Region, 2020

Figure 04: Global Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 05: Global Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 06: Global Interventional Pulmonology Market Revenue (US$ Mn), by Bronchoscopes, 2017–2031

Figure 07: Global Interventional Pulmonology Market Revenue (US$ Mn), by Electromagnetic Navigation Bronchoscopy Systems, 2017–2031

Figure 08: Global Interventional Pulmonology Market Revenue (US$ Mn), by Pleuroscopes, 2017–2031

Figure 09: Global Interventional Pulmonology Market Revenue (US$ Mn), by Respiratory Endotherapy Devices, 2017–2031

Figure 10: Global Interventional Pulmonology Market Revenue (US$ Mn), by Airway Stents, 2017–2031

Figure 11: Global Interventional Pulmonology Market Revenue (US$ Mn), by Pleural Catheters, 2017–2031

Figure 12: Global Interventional Pulmonology Market Revenue (US$ Mn), by Endobronchial Valves, 2017–2031

Figure 13: Global Interventional Pulmonology Market Revenue (US$ Mn), by Bronchial Thermoplasty Systems, 2017–2031

Figure 14: Global Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031

Figure 15: Global Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031

Figure 16: Global Interventional Pulmonology Market Revenue (US$ Mn), by Asthma, 2017–2031

Figure 17: Global Interventional Pulmonology Market Revenue (US$ Mn), by COPD, 2017–2031

Figure 18: Global Interventional Pulmonology Market Revenue (US$ Mn), by Lung Cancer, 2017–2031

Figure 19: Global Interventional Pulmonology Market Revenue (US$ Mn), by Tracheal & Bronchial Stenosis, 2017–2031

Figure 20: Global Interventional Pulmonology Market Revenue (US$ Mn), by Others, 2017–2031

Figure 21: Global Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031

Figure 22: Global Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 23: Global Interventional Pulmonology Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 24: Global Interventional Pulmonology Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

Figure 25: Global Interventional Pulmonology Market Revenue (US$ Mn), by Specialty Clinics, 2017–2031

Figure 26: Global Interventional Pulmonology Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 27: Global Interventional Pulmonology Market Revenue (US$ Mn), by Others, 2017–2031

Figure 28: Global Interventional Pulmonology Market Value Share Analysis, by Region, 2021 and 2031

Figure 29: Global Interventional Pulmonology Market Attractiveness Analysis, by Region, 2021–2031

Figure 30: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031

Figure 31: North America Interventional Pulmonology Market Value Share Analysis, by Country, 2021 and 2031

Figure 32: North America Interventional Pulmonology Market Attractiveness Analysis, by Country, 2021–2031

Figure 33: North America Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 34: North America Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 35: North America Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031

Figure 36: North America Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031

Figure 37: North America Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031

Figure 38: North America Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 39: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031

Figure 40: Europe Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 41: Europe Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 42: Europe Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 43: Europe Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 44: Europe Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031

Figure 45: Europe Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031

Figure 46: Europe Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031

Figure 47: Europe Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 48: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031

Figure 49: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 50: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 51: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 52: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 53: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031

Figure 54: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031

Figure 55: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031

Figure 56: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031

Figure 58: Latin America Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 59: Latin America Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 60: Latin America Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 61: Latin America Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 62: Latin America Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031

Figure 63: Latin America Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031

Figure 64: Latin America Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031

Figure 65: Latin America Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 66: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031

Figure 67: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 68: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 69: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 70: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 71: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031

Figure 72: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031

Figure 73: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031

Figure 74: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Interventional Pulmonology Market